Amylin (8-37), human

ArtNr	RP11276-0.5
Hersteller	GenScript
Menge	0.5 mg
Kategorie	Oncology Neuroscience Metabolism Diabetes Glucose Homeostasis Cholesterol & Lipid Metabolism Regulation of Appetite Molecular Targets for Neuroscience Peptides & Proteins Endocrine Regulation of Lipid Metabolism Peptides By Organ Breast Cancer
Typ	Peptides
Specific against	Human (Homo sapiens)
Purity	> 95%
Sequence	ATQRLANFLVHSSNNFGAILSSTNVGSNTY ; {ALA}{THR}{GLN}{ARG}{LEU}{ALA}{ASN}{PHE}{LEU}{VAL}{HIS}{SER}{SER}{ASN}{ASN}{PHE}{GLY}{ALA}{ILE}{LEU}{SER}{SER}{THR}{ASN}{VAL}{GLY}{SER}{ASN}{THR}{TYR}
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	peptide/RP11276-Amylin_8-37_human, Amylin (8-37) selectively inhibits insulin-stimulated glucose utilization and glycogen deposition in muscle. Amylin (8-37) is a truncated peptide of native rat smylin. Amylin (8-37) increases whole-body and muscle insulin sensitivity and consistently reduces basal insulin levels in normal and hGH-induced insulin-resistant rats. Amylin (8-37) also elicits a significant alteration of in-vivo lipid metabolism. </td></tr><tr><th>Solubility</th><td colspan="7"> The contents of this vial have been accurately determined. Both the stopper and the vial have been siliconized. Do not attempt to weigh out a smaller portion of the contents. </td></tr><tr><th>Purity</th><td colspan="7"> > 95% </td></tr><tr><th>Storage</th><td colspan="7"> Before use, store the peptide in the DRY form at 0C - 5C. For best and most repeatable results, rehydrate the peptide immediately before use. Do not re-freeze any unused portions.</td></tr>
Similar products	Amylin
Lieferbar
Country of Origin	USA
Storage Conditions	Before use, store the peptide in the DRY form at 0C - 5C. For best and most repeatable results, rehydrate the peptide immediately before use. Do not re-freeze any unused portions.
Description	Amylin (8-37) selectively inhibits insulin-stimulated glucose utilization and glycogen deposition in muscle. Amylin (8-37) is a truncated peptide of native rat smylin. Amylin (8-37) increases whole-body and muscle insulin sensitivity and consistently reduces basal insulin levels in normal and hGH-induced insulin-resistant rats. Amylin (8-37) also elicits a significant alteration of in-vivo lipid metabolism.
Solubility	The contents of this vial have been accurately determined. Both the stopper and the vial have been siliconized. Do not attempt to weigh out a smaller portion of the contents.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

Produkt-Datenblatt anfordern

Sicherheitsdatenblatt anfordern

Einfache Bestellung Periodische Bestellung

Menge: 0.5 mg

lieferbar

Lieferung vsl. bis 11.09.2025

Express-Lieferung: 3 Tage sparen

Vergleichen

Auf den Wunschzettel

Angebot anfordern